echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Clin Cancer Res: Intestinal bacteria predict the response of patients with advanced rectal cancer to new assisted chemotherapy!

    Clin Cancer Res: Intestinal bacteria predict the response of patients with advanced rectal cancer to new assisted chemotherapy!

    • Last Update: 2021-01-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Intestinal bacteriologies (GM) are involved in anti-tumor immunotherapy and chemotherapy responses, however, there is still less evidence-based research on the efficacy of intestinal bacteriologies in predicting the efficacy of new assisted chemotherapy (nCRT) in patients with localized advanced rectal cancer (LARC).
    this forward-looking longitudinal study is intended to assess the feasibility of predicting nCRT reactions in the gut microbiome.
    researchers collected 167 stool samples from 84 LARC patients before and after nCRT treatment and 16S rRNA sequencing from 31 healthy people.
    patients were divided into a response group and a non-response group based on the pathological response to nCRT.
    identified microbial biomarkers associated with nCRT reactions, the researchers constructed a random forest classifier from baseline samples from 37 patients and validated it in another group of 47 patients.
    significant microbiome changes were observed by bacillus researchers after treatment in patients with LARC and in patients with baseline bacteria treated with healthy control, as shown by a decrease in LARC-related pathogens and an increase in lactic acid bacteria and streptococcus during NCRT.
    , there were significant microbial differences in baseline samples of respondents and non-respondents.
    Microorganisms associated with butylate production, including Roche, Dorsey, and Anaerobic Lollipop, are the dominant bacterium groups among respondents, while Erythyl and Clostridium difficile are dominant among respondents.
    reaction-prediction classifier performance selected 10 biomarkers as reaction-predicted classifiers, including Dorsey, Anaerobic lollipop and streptococcus, with AAUC as high as 93.57% (95% CI 85.76%-100%) in the training queue and 73.53% (58.96%-88.11%) in the validation queue.
    addition, the gut microbiome provides new potential biomarkers for predicting patients' responses to nCRT treatment, and the results provide important guidance for the clinical management of such patients.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.